Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 54 Issue 12, December 2022

Cotton pan-genome

Pan-genome and pan-3D-genome analyses reveal evolutionary relationships between transposon-driven variations in genome size and chromatin topology innovation in the Gossypium genus, and delineate the genomic basis of the evolution of cotton fiber from coarse sparse to slender spinnable. Today, the allotetraploid cotton Gossypium hirsutum is widely cultivated around the world.

See Wang et al.

Image: Shuangxia Jin. Cover Design: Tulsi Voralia.

Editorial

  • Large-scale genotyping and phenotyping efforts, including biobanks, have revolutionized our understanding of the genetic architecture of human traits and diseases. Years of ever-larger genome-wide association studies (GWAS) have produced a catalog of genetic variants that contribute to complex traits. A corollary of this research has been the development of personalized polygenic scores (PGS) or polygenic risk scores (PRS).

    Editorial

    Advertisement

Top of page ⤴

Comment

  • It has been 25 years since the release of GATTACA, a film that tells the story of a credible near future in which society’s inequalities, formerly associated with race and class, have been replaced with new prejudices based on genetic determinism. Here we compare GATTACA’s fictional technologies with reality’s state of the art, assessing the legal protections afforded in today’s society against GATTACA’s dystopian future in which personal freedom and privacy rights are substantially curtailed by genomic innovations. We further discuss how GATTACA’s prescient forewarnings are still relevant today in light of the current trajectory of genomic science and technology.

    • Dov Greenbaum
    • Mark Gerstein
    Comment
  • The Qatar Genome Program was established to interrogate the genomics and genetics of populations in the Middle East. Improving precision medicine strategies and building long-term research capacity are both key aims of the initiative.

    • Hamdi Mbarek
    • Said I. Ismail
    Comment
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Previous genome-wide association studies of coronary artery disease (CAD) have discovered multiple susceptibility loci but have largely failed to uncover causal genes. A new study identifies hundreds of likely causal genes underlying the genetic risk for CAD.

    • Paul L. Auer
    News & Views
  • K27M mutation of histone H3 has been identified as a driver event in diffuse midline glioma. Two studies used comprehensive multi-model single-cell genomic, epigenomic and chromatin structure analysis to characterize the cell of origin and find a distinct etiology of H3K27M between pontine and thalamic tumors, and show that pontine gliomas harbor more immature oligodendrocyte-precursor-like cells.

    • Xiao-Nan Li
    News & Views
  • Mutations in the sodium channel NALCN promote epithelial cell shedding and dissemination independent of oncogenic transformation. This observation suggests that metastasis may not uniformly represent the end stage of carcinogenesis but can occur before oncogenic transformation.

    • Ana Rita Nobre
    • Adrienne Boire
    News & Views
  • Few genetic alterations have been linked to metastasis, during which cancer cells acquire abnormal migratory behavior. A new study sheds light on how loss of NECTIN1 leads to melanoma dissemination after local depletion of IGF1.

    • Jaume Barcelo
    • Victoria Sanz-Moreno
    News & Views
Top of page ⤴

Research Briefings

  • We developed a CRISPR-based functional assay for genetic sequence variants found in human disease, probing their effects on cell proliferation, survival, motility and any physiological or pathological process measurable by fluorescence-activated cell sorting (FACS). The assay accurately assessed variant pathogenicity, drug responsiveness or resistance and mechanistic role in disease, in vitro and in vivo.

    Research Briefing
Top of page ⤴

Brief Communications

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Technical Reports

Top of page ⤴

Search

Quick links